{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:56Z","timestamp":1793946416733,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yexcr.2026.115017","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:07:16Z","timestamp":1775437636000},"page":"115017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism of ginkgetin in inducing immunogenic cell death of gastric cancer cells by inhibiting the STAT3 signaling"],"prefix":"10.1016","volume":"459","author":[{"given":"Qianqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9688","key":"10.1016\/j.yexcr.2026.115017_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(09)60617-6","article-title":"Gastric cancer","volume":"374","author":"Hartgrink","year":"2009","journal-title":"Lancet"},{"issue":"10251","key":"10.1016\/j.yexcr.2026.115017_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115017_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115017_bib4","first-page":"592","article-title":"Advances in gastric cancer treatment in 2024: key breakthroughs and emerging trends","volume":"36","author":"Wei","year":"2024","journal-title":"Chin. J Cancer Res. = Chung-kuo yen cheng yen chiu"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115017_bib5","first-page":"937","article-title":"Gastric cancer in China: epidemiology, risk factors, and screening","volume":"37","author":"Wang","year":"2025","journal-title":"Chin. J. Cancer Res. = Chung-kuo yen cheng yen chiu"},{"issue":"30","key":"10.1016\/j.yexcr.2026.115017_bib6","article-title":"Nanoparticle-mediated CXCL12-CXCR4 inhibition reprograms macrophages and suppresses gastric carcinoma","volume":"12","author":"Cao","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115017_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/SLA.0000000000002116","article-title":"ImmunoScore signature: a prognostic and predictive tool in gastric cancer","volume":"267","author":"Jiang","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.yexcr.2026.115017_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/CMAR.S149619","article-title":"Gastric cancer: epidemiology, prevention, classification, and treatment","volume":"10","author":"Sitarz","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-013-0252-z","article-title":"HER2-positive gastric cancer","volume":"17","author":"Boku","year":"2014","journal-title":"Gastric Cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115017_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121487","article-title":"Nanoparticle-delivered transforming growth Factor-\u03b21 siRNA induces PD-1 against gastric cancer by transforming the phenotype of the tumor immune microenvironment","volume":"15","author":"Wu","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115017_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.surg.2021.07.034","article-title":"Anastomotic stricture after Ivor Lewis esophagectomy: an evaluation of incidence, risk factors, and treatment","volume":"171","author":"Koshy","year":"2022","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115017_bib12","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.cgh.2021.03.046","article-title":"AGA clinical practice update on the optimal management of the malignant alimentary tract obstruction: expert review","volume":"19","author":"Ahmed","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7517","key":"10.1016\/j.yexcr.2026.115017_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115017_bib14","first-page":"38","article-title":"Effects of FAP(+) cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4(+) T cell polarization in gastric cancer","volume":"8","author":"Wu","year":"2025","journal-title":"Cancer drug resistance (Alhambra, Calif)"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115017_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s10120-019-00974-4","article-title":"Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact","volume":"22","author":"Kim","year":"2019","journal-title":"Gastric Cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115017_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrclinonc.2011.122","article-title":"Cancer immunology--analysis of host and tumor factors for personalized medicine","volume":"8","author":"Ogino","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7890","key":"10.1016\/j.yexcr.2026.115017_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","article-title":"The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer","volume":"600","author":"Janjigian","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.yexcr.2026.115017_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","article-title":"Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial","volume":"17","author":"Muro","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12951-022-01576-6","article-title":"Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K\/Akt\/mTOR signaling pathway","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115017_bib20","first-page":"187","article-title":"Immunosurveillance in clinical cancer management","volume":"74","author":"Kroemer","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"10.1016\/j.yexcr.2026.115017_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202309994","article-title":"Chimeric peptide-engineered self-delivery nanomedicine for photodynamic-triggered breast cancer immunotherapy by macrophage polarization","volume":"20","author":"Liu","year":"2024","journal-title":"Small"},{"issue":"26","key":"10.1016\/j.yexcr.2026.115017_bib22","doi-asserted-by":"crossref","first-page":"33169","DOI":"10.1021\/acsami.4c06149","article-title":"Self-delivery nanobooster to enhance immunogenic cell death for cancer chemoimmunotherapy","volume":"16","author":"Yan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.yexcr.2026.115017_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116620","article-title":"Marsdenia tenacissima extract induces endoplasmic reticulum stress-associated immunogenic cell death in non-small cell lung cancer cells through targeting AXL","volume":"314","author":"Yuan","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115017_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/md21040225","article-title":"The blockade of mitogen-activated protein kinase 14 activation by marine natural product crassolide triggers ICD in tumor cells and stimulates anti-tumor immunity","volume":"21","author":"Tsai","year":"2023","journal-title":"Mar. Drugs"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115017_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/anie.201804882","article-title":"Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy","volume":"58","author":"Duan","year":"2019","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.yexcr.2026.115017_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155503","article-title":"Natural products and derivatives in renal, urothelial and testicular cancers: targeting signaling pathways and therapeutic potential","volume":"127","author":"Li","year":"2024","journal-title":"Phytomedicine : Int. J. Phytotherapy phytopharm."},{"issue":"6","key":"10.1016\/j.yexcr.2026.115017_bib27","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/pca.70003","article-title":"Recent advances in analytical methods for Aconitine alkaloid in natural products: a systematic review","volume":"36","author":"Ahmad","year":"2025","journal-title":"Phytochem. Anal. : PCA"},{"key":"10.1016\/j.yexcr.2026.115017_bib28","article-title":"Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s13659-025-00535-6","article-title":"Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy","volume":"15","author":"Xiong","year":"2025","journal-title":"Natural products and bioprospecting"},{"issue":"19","key":"10.1016\/j.yexcr.2026.115017_bib30","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/CM9.0000000000003247","article-title":"Ginkgo biloba derivative ginkgetin inhibits breast cancer growth by regulating the miRNA-122-5p\/GALNT10 axis","volume":"137","author":"Alu","year":"2024","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.yexcr.2026.115017_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153370","article-title":"Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2\/HO-1 axis in EGFR wild-type non-small-cell lung cancer","volume":"80","author":"Lou","year":"2021","journal-title":"Phytomedicine : Int. J. Phytotherapy Phytopharm."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115017_bib32","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.7150\/thno.106469","article-title":"TFEB promotes Ginkgetin-induced ferroptosis via TRIM25 mediated GPX4 lysosomal degradation in EGFR wide-type lung adenocarcinoma","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2026.115017_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2018.11.027","article-title":"Ginkgetin, a biflavone from Ginkgo biloba leaves, prevents adipogenesis through STAT5-mediated PPAR\u03b3 and C\/EBP\u03b1 regulation","volume":"139","author":"Cho","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115017_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2174\/1389557517666161104130026","article-title":"Biological and chemical aspects of natural biflavonoids from plants: a brief review","volume":"17","author":"Gontijo","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115017_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/cas.12608","article-title":"Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity","volume":"106","author":"Jeon","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2026.115017_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111642","article-title":"Ginkgetin: a natural biflavone with versatile pharmacological activities","volume":"145","author":"Adnan","year":"2020","journal-title":"Food Chem. Toxicol. : an international journal published for the British Industrial Biological Research Association"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13659-023-00401-3","article-title":"Marine natural product lepadin A as a novel inducer of immunogenic cell death via CD91-dependent pathway","volume":"13","author":"Carbone","year":"2023","journal-title":"Nat Prod Bioprospect"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115017_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12951-023-02067-y","article-title":"Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1\/PD-L1 for residual tumors immunotherapy after RFA","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115017_bib40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/ijo.2015.3160","article-title":"The JAK\/STAT signaling cascade in gastric carcinoma","volume":"47","author":"Khanna","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.yexcr.2026.115017_bib41","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.7150\/ijbs.35265","article-title":"Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS","volume":"15","author":"Cao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115017_bib42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol."},{"issue":"5 Suppl 15","key":"10.1016\/j.yexcr.2026.115017_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Semin. Oncol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115017_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"11","key":"10.1016\/j.yexcr.2026.115017_bib45","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.7150\/ijbs.59404","article-title":"Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells","volume":"17","author":"Wei","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115017_bib46","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.7150\/ijbs.70975","article-title":"A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway","volume":"18","author":"Wen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12906-023-04221-3","article-title":"Afzelin induces immunogenic cell death against lung cancer by targeting NQO2","volume":"23","author":"Xia","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115017_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115017_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch: immunogenic cell death induction by anticancer chemotherapeutics","volume":"6","author":"Garg","year":"2017","journal-title":"OncoImmunology"},{"issue":"5","key":"10.1016\/j.yexcr.2026.115017_bib51","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/emboj.2012.2","article-title":"Enlightening the impact of immunogenic cell death in photodynamic cancer therapy","volume":"31","author":"Galluzzi","year":"2012","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115017_bib52","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1039\/D1CS00417D","article-title":"Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future","volume":"51","author":"Sen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"26","key":"10.1016\/j.yexcr.2026.115017_bib54","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115017_bib55","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115017_bib56","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-Regulated Fatty acid \u03b2-Oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115017_bib58","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115017_bib59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10565-025-10050-6","article-title":"NFATC2\/SERPINE1\/JAK3\/STAT3 signaling feedback loop in gastric cancer: immune evasion and anti-PD-1 resistance","volume":"41","author":"Yang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"10.1016\/j.yexcr.2026.115017_bib60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gutjnl-2024-332901","article-title":"Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages","volume":"74","author":"Lee","year":"2025","journal-title":"Gut"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:41:21Z","timestamp":1793943681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0014482726001345"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115017","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of ginkgetin in inducing immunogenic cell death of gastric cancer cells by inhibiting the STAT3 signaling","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115017"}}